• Citer

Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.

par Snoeck, Robert ;Bossens, Michel ;Parent, Dominique ;Delaere, Bénédicte;Degreef, Hugo;Van Ranst, Marc;Noël, Jean Christophe ;Wulfsohn, M S;Rooney, J F;Jaffe, H S;De Clercq, Els
Référence Clinical infectious diseases, 33, 5, page (597-602)
Publication Publié, 2001-09

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.
Auteur:	Snoeck, Robert; Bossens, Michel; Parent, Dominique; Delaere, Bénédicte; Degreef, Hugo; Van Ranst, Marc; Noël, Jean Christophe; Wulfsohn, M S; Rooney, J F; Jaffe, H S; De Clercq, Els
Informations sur la publication:	Clinical infectious diseases, 33, 5, page (597-602)
Statut de publication:	Publié, 2001-09
Sujet CREF:	Dermatologie
MeSH keywords:	Adult
	Antiviral Agents -- therapeutic use
	Cytosine -- analogs & derivatives -- therapeutic use
	Female
	Humans
	Male
	Middle Aged
	Organophosphorus Compounds -- therapeutic use
	Papillomaviridae -- drug effects -- isolation & purification
	Papillomavirus Infections -- drug therapy
	Phosphonic Acids
	Risk Factors
	Treatment Outcome
	Tumor Virus Infections -- drug therapy
Note générale:	Clinical Trial
	Clinical Trial, Phase II
	Journal Article
	Randomized Controlled Trial
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1058-4838
	info:doi/10.1086/322593
	info:pii/CID001135
	info:scp/0035451685
	info:pmid/11477525